Showing 1 - 4 results of 4 for search 'Krendyukov, A', query time: 0.03s Refine Results
  1. 1
    Asunercept as an innovative therapeutic approach for recurrent glioblastoma and other malignancies

    Asunercept as an innovative therapeutic approach for recurrent glioblastoma and other malignancies by Krendyukov A, Gieffers C

    Published 2019-09-01
    Get full text
    Article
  2. 2
    CD95L and Anti-Tumor Immune Response: Current Understanding and New Evidence

    CD95L and Anti-Tumor Immune Response: Current Understanding and New Evidence by Richards DM, Merz C, Gieffers C, Krendyukov A

    Published 2021-03-01
    Get full text
    Article
  3. 3
    HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experience

    HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experience by Dellanna F, Goldsmith D, Krendyukov A, Seidl A, Höbel N, Combe C

    Published 2017-12-01
    Get full text
    Article
  4. 4
    The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model

    The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model by Krendyukov, A, Kneisel, N, Zhu, J, Merz, C, Richards, D, Gieffers, C, Van Den Eynde, B

    Published 2020
    Conference item

Search Tools: